Adrienne Jo

Adrienne is a PhD Senior Associate Intern at Palo Santo, an investment fund focused on advancing psychedelic therapeutics for mental health. Simultaneously, she is pursuing a Neuropharmacology PhD at the University of Pennsylvania and has actively supported Philadelphia-based academic life sciences bioentrepreneurship as Co-Managing Director of Nucleate Philadelphia. Adrienne believes that scientifically rigorous innovations in the psychedelic space harbor immense promise in revolutionizing our treatment paradigm in a myriad of CNS disorders.